Half-year report · HY
6894.TEDINET S100X3FK
Period2025-04-01 → 2025-09-30
Filed2025-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.0bn | 2025-04-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥2.5bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥972m | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Operating income | ¥89m | 2025-04-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | ¥56m | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | ¥100m | 2025-04-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥354m | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥53m | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥100m | 2025-04-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥39m | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥71m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥356m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥25m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥71m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | ¥25m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥4.8bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥5.0bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥4.4bn | at 2024-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥963m | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥1.2bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥3.8bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥3.9bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.5bn | at 2024-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.9bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.0bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.9bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.9bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.7bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.3bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥283m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥153m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥157m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥144m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥375m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥247m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥152m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥159m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥154m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥51.83 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥260.19 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥18.55 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 79.7% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 76.8% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 79.6% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 24
| Segment | Item | Period | Value |
|---|---|---|---|
| Healthcare Related Productsreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥265m |
| Healthcare Related Productsreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥265m |
| Healthcare Related Productsreportable segment | segment profit | 2025-04-01 → 2025-09-30 | −¥130,000 |
| Optical Applications And Special Customized Productsreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥397m |
| Optical Applications And Special Customized Productsreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥397m |
| Optical Applications And Special Customized Productsreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥100m |
| X Ray Residual Stress Analyzerreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥379m |
| X Ray Residual Stress Analyzerreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥379m |
| X Ray Residual Stress Analyzerreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥136m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-04-01 → 2025-09-30 | ¥1.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-04-01 → 2025-09-30 | ¥1.0bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-04-01 → 2025-09-30 | ¥236m |
| Healthcare Related Productsreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥375m |
| Healthcare Related Productsreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥375m |
| Healthcare Related Productsreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥37m |
| Optical Applications And Special Customized Productsreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥353m |
| Optical Applications And Special Customized Productsreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥353m |
| Optical Applications And Special Customized Productsreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥100m |
| X Ray Residual Stress Analyzerreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥244m |
| X Ray Residual Stress Analyzerreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥244m |
| X Ray Residual Stress Analyzerreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥70m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥972m |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥972m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥207m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 417
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares held | InterimInstant_No2MajorShareholdersMember | 115073 | |
| Shareholding ratio | InterimInstant_No2MajorShareholdersMember | 0.0841 | |
| Number of shares held | InterimInstant_No3MajorShareholdersMember | 51297 | |
| Shareholding ratio | InterimInstant_No3MajorShareholdersMember | 0.0375 | |
| Number of shares held | InterimInstant_No4MajorShareholdersMember | 37000 | |
| Shareholding ratio | InterimInstant_No4MajorShareholdersMember | 0.0270 | |
| Number of shares held | InterimInstant_No5MajorShareholdersMember | 36940 | |
| Shareholding ratio | InterimInstant_No5MajorShareholdersMember | 0.0270 | |
| Number of shares held | InterimInstant_No6MajorShareholdersMember | 36600 | |
| Shareholding ratio | InterimInstant_No6MajorShareholdersMember | 0.0268 | |
| Number of shares held | InterimInstant_No7MajorShareholdersMember | 36100 | |
| Shareholding ratio | InterimInstant_No7MajorShareholdersMember | 0.0264 | |
| Number of shares held | InterimInstant_No8MajorShareholdersMember | 33500 | |
| Shareholding ratio | InterimInstant_No8MajorShareholdersMember | 0.0245 | |
| Number of shares held | InterimInstant_No9MajorShareholdersMember | 28800 | |
| Shareholding ratio | InterimInstant_No9MajorShareholdersMember | 0.0211 | |
| Number of shares held | InterimInstant_No10MajorShareholdersMember | 25000 | |
| Shareholding ratio | InterimInstant_No10MajorShareholdersMember | 0.0183 | |
| Number of shares held | InterimInstant | 527010 | |
| Shareholding ratio | InterimInstant | 0.3852 | |
| Number of shares issued shares voting rights | InterimInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | InterimInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 25300 | |
| Number of shares issued shares voting rights | InterimInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 1353900 | |
| Number of voting rights issued shares voting rights | InterimInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 13539 | |
| Number of shares issued shares voting rights | InterimInstant_OrdinarySharesSharesLessThanOneUnitMember | 14259 | |
| Number of shares issued shares voting rights | InterimInstant | 1393459 | |
| Number of voting rights issued shares voting rights | InterimInstant | 13539 | |
| Number of shares held in own name treasury shares etc | InterimInstant_Row1Member | 25300 | |
| Number of shares held in others names treasury shares etc | InterimInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | InterimInstant_Row1Member | 25300 | |
| Shareholding ratio treasury shares etc | InterimInstant_Row1Member | 0.0182 | |
| Number of shares held in own name treasury shares etc | InterimInstant | 25300 | |
| Number of shares held in others names treasury shares etc | InterimInstant | － | |
| Total number of shares held treasury shares etc | InterimInstant | 25300 | |
| Shareholding ratio treasury shares etc | InterimInstant | 0.0182 | |
| Cash and deposits | Prior1YearInstant | 1952139000 | JPY |
| Cash and deposits | InterimInstant | 1922684000 | JPY |
| Notes and accounts receivable trade and contract assets | Prior1YearInstant | 858299000 | JPY |
| Notes and accounts receivable trade and contract assets | InterimInstant | 578990000 | JPY |
| Work in process | Prior1YearInstant | 407103000 | JPY |
| Work in process | InterimInstant | 486482000 | JPY |
| Raw materials and supplies | Prior1YearInstant | 366645000 | JPY |
| Raw materials and supplies | InterimInstant | 330261000 | JPY |
| Other ca | Prior1YearInstant | 25153000 | JPY |
| Other ca | InterimInstant | 15751000 | JPY |
| Current assets | Prior1YearInstant | 3609341000 | JPY |
| Current assets | InterimInstant | 3334171000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |